April 30th 2024
The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Study Results Show Possible Link Between Medicaid Expansion, Drop in Advanced Breast Cancer
July 1st 2020Despite ongoing disparities in the use of health care services among races/ethnicities and ages, as well as by insurance status, African American women with advanced breast cancer benefited the most following implementation of the Affordable Care Act in states that chose to expand Medicaid coverage.
Read More
Novel Subcutaneous, At-Home Breast Cancer Treatment Approved
June 30th 2020The FDA approved Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf) as a subcutaneous (SC) treatment for adult patients with metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer or early-stage HER-2 positive disease. The treatment combines 2 monoclonal antibodies in a single SC injection.
Read More
Previous Breast Cancer Therapy Not Likely to Affect Outcomes in Patients With COVID-19
June 26th 2020Results from an analysis of patients with breast cancer and coronavirus disease 2019 (COVID-19), from Institut Curie hospitals in France, show that mortality is determined more by comorbidities than previous or current treatment for the cancer.
Read More
Black Women With Insulin Resistance May Have Worse Breast Cancer Prognosis
June 24th 2020Elevated insulin levels, which have been shown to promote tumor growth, due to insulin resistance may be linked to a greater prevalence of invasive breast cancer among black women compared with white women.
Read More
High-Dose Chemo Most Benefits Patients With High-Risk Breast Cancer
June 11th 2020A 20-year follow-up comprising a secondary analysis to an original study shows that high-dose chemotherapy plus hematopoietic stem cell transplant benefit patients with high-risk stage III disease with 10 or more axillary lymph nodes involved.
Read More
Postmenopausal Women With Breast Cancer Show Decreased Brain Health, Cognitive Function
June 8th 2020Previous studies show that up to 75% of women with breast cancer exhibit disease- and treatment-related affects that include poorer cognitive function in the forms of psychological well-being, decision making, and adherence to treatment.
Read More
Long-Term Risk of Invasive Breast Cancer Increases Following a Diagnosis of DCIS
May 28th 2020In the 2 decades following their diagnosis for ductal carcinoma in situ (DCIS), women in a study out of England demonstrated a greater risk of invasive breast cancer and mortality compared with the general population. Overall, DCIS represents close to 20% of screening-detected breast cancers every year.
Read More
Women Frequently Encounter Employment, Insurance Issues After Breast Cancer Diagnosis
May 24th 2020A majority of women younger than 45 years faced employment and insurance coverage difficulties following treatment for early stage breast cancer, with 35% fearing loss of health insurance coverage if they left their current job during treatment—despite wanting to continue working.
Read More